Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03728829 |
|
Recruitment Status : Unknown
Verified July 2021 by Liu Yunjiang, Hebei Medical University Fourth Hospital.
Recruitment status was: Recruiting
First Posted : November 2, 2018
Last Update Posted : July 9, 2021
|
Sponsor:
Hebei Medical University Fourth Hospital
Collaborator:
OrigiMed
Information provided by (Responsible Party):
Liu Yunjiang, Hebei Medical University Fourth Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | October 30, 2022 |
| Estimated Study Completion Date : | December 31, 2022 |